200
Participants
Start Date
May 1, 2020
Primary Completion Date
January 31, 2026
Study Completion Date
January 31, 2026
multiparametric MRI Diagnostics
Patients with newly diagnosed prostate cancer enrolled in active surveillance following standard protocol including PSA, DRE and TRUS biopsies and intervention with multiparametric MRI + additional biopsies if suspicious lesions are found
Department of Urology, Herlev University Hospital Herlev, Herlev
Herlev Hospital
OTHER